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ORIGINAL ARTICLE
Common polygenic risk for autism spectrum disorder (ASD) is
associated with cognitive ability in the general population
T-K Clarke1, MK Lupton2, AM Fernandez-Pujals1, J Starr3, G Davies3, S Cox3, A Pattie3, DC Liewald3, LS Hall1, DJ MacIntyre1, BH Smith4,
LJ Hocking4, S Padmanabhan5, PA Thomson3,4,5,6, C Hayward6,7, NK Hansell2, GW Montgomery2, SE Medland2, NG Martin2, MJ Wright2,
DJ Porteous3,4,5,6,7,8, IJ Deary3,4,5,6,7,8,9 and AM McIntosh1,3
Cognitive impairment is common among individuals diagnosed with autism spectrum disorder (ASD) and attention-deficit
hyperactivity disorder (ADHD). It has been suggested that some aspects of intelligence are preserved or even superior in people
with ASD compared with controls, but consistent evidence is lacking. Few studies have examined the genetic overlap between
cognitive ability and ASD/ADHD. The aim of this study was to examine the polygenic overlap between ASD/ADHD and cognitive
ability in individuals from the general population. Polygenic risk for ADHD and ASD was calculated from genome-wide association
studies of ASD and ADHD conducted by the Psychiatric Genetics Consortium. Risk scores were created in three independent
cohorts: Generation Scotland Scottish Family Health Study (GS:SFHS) (n= 9863), the Lothian Birth Cohorts 1936 and 1921 (n= 1522),
and the Brisbane Adolescent Twin Sample (BATS) (n= 921). We report that polygenic risk for ASD is positively correlated with
general cognitive ability (beta = 0.07, P= 6× 10− 7, r2 = 0.003), logical memory and verbal intelligence in GS:SFHS. This was replicated
in BATS as a positive association with full-scale intelligent quotient (IQ) (beta = 0.07, P= 0.03, r2 = 0.005). We did not find consistent
evidence that polygenic risk for ADHD was associated with cognitive function; however, a negative correlation with IQ at age
11 years (beta =− 0.08, Z=− 3.3, P= 0.001) was observed in the Lothian Birth Cohorts. These findings are in individuals from the
general population, suggesting that the relationship between genetic risk for ASD and intelligence is partly independent of clinical
state. These data suggest that common genetic variation relevant for ASD influences general cognitive ability.
Molecular Psychiatry advance online publication, 10 March 2015; doi:10.1038/mp.2015.12
INTRODUCTION
Autism spectrum disorder (ASD) and attention-deficit hyperactivity
disorder (ADHD) are pervasive neurodevelopmental disorders that
manifest during childhood. These disorders are highly heritable,1–4
and recent genome-wide association studies (GWAS) have found
that a portion of this heritability is attributable to common genetic
variants.5 Cognitive difficulties are common in individuals with
ADHD or ASD. Children with ADHD have been found to have
a 7–12 point lower average full-scale intelligent quotient (FIQ)
compared with controls.6,7 Furthermore, individuals with ADHD
demonstrate reduced working memory capacity and poorer
processing speed and reading comprehension.8–11 Executive func-
tion deficits in children with ADHD have been found to persist into
adulthood12 despite remission of ADHD symptoms13,14 although
other studies find that impairment persists only in individuals
whose ADHD remains.15 The relationship between autism and
intelligence is, however, more complex. The majority of autistic
individuals are intellectually impaired16 although a few studies
have shown areas of superior functioning compared with
controls,17 particularly on non-verbal measures.18,19
General cognitive ability (g) is a latent trait that can be extracted
from performance across diverse tests of cognitive aptitude. General
cognitive ability has heritability estimates of approximately 30% in
young childhood20 increasing to 80% in adolescence.21 Like ADHD
and ASD, differences in general cognitive ability are highly
polygenic, with about half of the heritability captured by common
genetic variants.22–24 Despite a strong phenotypic relationship
between autism, ADHD and cognitive decrements, few studies
have examined the genetic overlap between these traits. A study
examining the genetic correlation between five psychiatric dis-
orders did not find significant genetic overlap between ADHD and
ASD attributable to common single-nucleotide polymorphisms
(SNPs).5 Twin studies suggest that there are shared genetic effects
across autism,25,26 ADHD and cognitive ability7,27 although these
studies are confounded by the clinical state of the affected
individuals. Poor cognitive ability may arise via the social and
communicative impairments present in autistic or ADHD individ-
uals or the pleiotropic effect of genetic risk variants on cognition.
A recent study found that rare copy number variants that increase
risk for autism are associated with cognitive differences in healthy
controls. Control carriers of the 16p11.2 deletion were significantly
impaired on measures of verbal intelligence, working memory and
executive function.28 However, no study to our knowledge has
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assessed the relationship between common genetic risk for ASD
or ADHD and cognitive function in the general population.
The genetic overlap between different heritable traits can
be investigated using polygenic risk profiling. This method takes
the SNP effect sizes from a reference study and calculates the
genome-wide weighted sum of the alleles that an individual
carries, which then serves as an index of the genetic load for a
particular disorder. This method has the advantage of analysing
genetic overlap between cognitive ability, ADHD and ASD, without
the confounding effect of disease state.
The aim of this study was to test whether ADHD and ASD
polygenic profile scores29 are associated with cognitive ability in a
large population-based cohort. Generation Scotland: Scottish
Family Health Study (GS:SFHS)30 provides genome-wide genotyp-
ing data and four measures of cognitive function for 9863 individ-
uals, some of whom are in family groups. Two other samples: the
combined Lothian birth cohorts 1921 and 1936 (LBC1921 and
LBC1936) (1522 individuals combined)31 and the Brisbane Adolescent
Twin Study (BATS)32 were used for replication. LBC1921 and
LBC1936 provided measures of cognitive function in childhood
and old age for the same individuals. BATS consisted of 921 individ-
uals with cognitive ability measured in adolescence. We hypothe-
sized that individuals with a greater burden of ADHD or ASD risk
alleles would perform worse on tests of cognitive function,
consistent with findings in affected individuals. We also sought to
test whether individuals with a high genetic load for ASD would
perform better on non-verbal cognitive measures, similar to
autistic individuals.
METHODS
Cohort description and cognitive testing
Generation Scotland: Scottish Family Health Study (GS:SFHS). GS:SFHS is a
family-based epidemiological cohort; the protocol for recruitment is de-
scribed in detail in the Supplementary Materials and in previous
publications.30 Briefly, genome-wide SNP data were ascertained for 9863
individuals (mean age= 52.2 years, s.d. = 13.64), 5788 females and 4075
males (6815 unrelated participants). Four tests of cognitive function were
available: Mill Hill vocabulary scale junior and senior synonyms,33 verbal
declarative memory (logical memory),34 the Wechsler digit symbol sub-
stitution task (digit symbol coding (DSC)),34 and verbal fluency. A measure
of general cognitive ability was derived by entering all four cognitive tests
into a principal components analysis (PCA) and extracting the first
unrotated principal component,35 which explained 44% of the variance
across these tests. Each test loaded moderately onto the component (0.48–
0.54). Further details on cognitive testing are included in the Supple-
mentary Materials and summarized in Supplementary Table S1.
Lothian Birth Cohort 1936 (LBC1936). The 1936 Lothian Birth Cohort
(LBC1936) participants used in the present study consisted of 1005 (496
males and 509 females) community-dwelling individuals mostly living in
and around the City of Edinburgh, Scotland. Almost all of them completed
the Moray House Test (MHT) during the Scottish Mental Health Survey of
1947 at age 11 years, which was re-administered at a follow-up assessment
at age 70 years (Scottish Research Council, 1933).36,37 At age 70 years in
LBC1936, the National Adult Reading Test (NART)38 and tests of logical
memory, digit span backwards, spatial span and verbal paired associates
were administered from the Wechsler memory scale (WMS-III UK).39 Tests
from the Wechsler adult intelligence scale (WAIS-III) were also administered
at age 70 years: DSC, block design, letter number sequencing, and matrix
reasoning.34,40 Verbal fluency41 and lifetime change in IQ were also
assessed. General cognitive ability was constructed in LBC1936 by per-
forming PCA of block design, matrix reasoning, letter number sequencing,
digit span backwards, symbol search and DSC and extracting the first
principal component. This component explained 53% of the variance
across these six tests, (loading range 0.37–0.43). The LBC1936 cognitive
tests are described in greater detail in the Supplementary Methods and
summarized in Supplementary Table S1.
Lothian Birth Cohort 1921 (LBC1921). The 1921 Lothian birth cohort
(LBC1921) contributed 517 participants to the present study, 302 females
and 215 males who completed the MHT at age 11 years as part of the
Scottish Mental Health Survey in 1932.42,43 The MHT was completed again
at age 79 years. Participants completed the MHT at mean age 11 years and
then again at mean age 79 years.31 At age 79 years, tests of logical memory,39
verbal fluency41 and Raven’s progressive matrices33 were administered.
These three tests were entered into PCA to derive general cognitive ability,
and the first principal component explained 52% of the variance across
these tests (loadings 0.58–0.64), summarized in Supplementary Table S1.
Change in IQ from age 11 to age 79 years was ascertained as described for
LBC1936.
Brisbane Adolescent Twin Sample (BATS). BATS consists of 4500 individuals
(~1800 families) and targets twin adolescents and their siblings, with the
majority recruited through primary and secondary schools in South East
Queensland.32 The present study used 921 genotyped individuals randomly
selected, 1 per family (53.2% females; mean age= 16.7 years, s.d. = 1.6).
Measures of cognitive function included FIQ44 (N= 902), verbal IQ (VIQ)
(Subtests: Information, Vocabulary, Arithmetic; N=903) and performance
IQ (Spatial, Object Assembly; N=902). Processing speed was obtained from
the Digit Symbol Substitution task, a subtest of the Wechsler Adult
Intelligence Scale (WAIS-R)40 (N=874). Reading ability was assessed using a
contextualized version of the NART45 (N= 813). The tests used to create FIQ
are summarized in Supplementary Table S1.
Genotyping
GS:SFHS. Details of DNA extraction are described elsewhere.30 Briefly,
blood samples were collected using standard operating procedures and
stored using a laboratory information management system at the Wellcome
Trust Clinical Research Facility Genetics Core, Edinburgh, UK (www.
wtcrf.ed.ac.uk). DNA samples were genotyped by the WT-CRF using the
IlluminaHumanOmniExpressExome -8v1.0 BeadChip (San Diego, CA,
USA) and Infinum chemistry.46 Genotypes were processed using the
GenomeStudio Analysis software v2011.1 (Illumina).
Lothian birth cohorts. Samples were subject to genome-wide genotyping
via the extraction of venous blood from participants and genotyping at
the Wellcome Trust Clinical Research Facility, Edinburgh, UK (www.wtcrf.
ed.ac.uk). Genotyping was performed using the Illumina 610-Quadv1
whole-genome SNP array (Illumina, San Diego, CA, USA). The sample
collection, quality control and genotyping process is described in greater
detail elsewhere.47
BATS. Genome-wide genotyping data was collected (from DNA extracted
from venous blood) using the Illumina 610-Quadv1 whole-genome SNP
array. Quality control and imputation was carried out using the ENIGMA
(Enhancing Neuro Imaging Genetics through Meta-Analysis) protocols.48
Imputation was carried out to the 1000G phase1 integrated reference
panel (April 2012, NCBI build 37) using MiniMac, a computationally efficient
implementation of the MaCH algorithm.49
Polygenic profiling
The method to create polygenic risk scores has been previously des-
cribed50 and is implemented in PLINK.51 Further detail is included in the
Supplementary Methods. Summary statistics from the Psychiatric Genetics
Consortium (PGC) cross-disorder GWAS, consisting of 4788 ASD trio cases,
4788 trio ASD pseudo controls, 161 ASD cases, 526 ASD controls and 1947
ADHD trio cases, 1947 trio ADHD pseudo controls, 840 ADHD cases and
688 ADHD controls,5 were used as the discovery set to create polygenic
risk scores for ASD and ADHD. The PGC GWAS of ADHD and ASD explained
28% and 17% of the variance in liability to those disorders, respectively.5,29
Any SNPs genotyped or imputed in our cohorts were used to create the
polygenic risk scores, not just those showing statistically significant asso-
ciations in the original GWAS. Five SNP set scores were generated, using
P-value threshold cutoffs of 0.01, 0.05, 0.1, 0.5 and 1 from the original
GWAS; however, as the SNP-set derived from a P-value threshold o0.5
explained the greatest amount of variance in cognitive function (Figure 1),
only these results are presented throughout. Profile scores were generated
using raw genotype data for GS:SFHS and the LBC. Polygenic profiling for
the BATS cohort was performed on data imputed to the 1000 genomes
data set using the ENIGMA2 protocol described elsewhere.48 For com-
parability of results, we calculated profile scores for GS:SFHS and the LBC
using imputed genotypes and found the results to be largely consistent
(see Supplementary Materials for details).
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Statistical analyses
Generation of Scotland cohort. Mixed linear model analyses were
implemented in ASReml-R (www.vsni.co.uk/software/asreml), with cogni-
tive test scores as the dependent variable and age, sex, the first four MDS
components and polygenic risk score as fixed effects. Family structure was
fitted as a random effect by creating the inverse of a relationship matrix
using pedigree kinship information. P-values for fixed effects were
calculated using Wald’s conditional F-test. In order to calculate the
variance in cognitive test scores explained by polygene score, the
change in the sum of residual variance and the additive genetic variance
after removing the polygenic risk score from the model and then dividing
this by the sum of residual variance and the additive genetic variance.
There is a substantial male preponderance in ASD and ADHD, and
therefore the interaction between sex and each polygenic risk score was
also analysed by fitting an interaction term in each model (Supplementary
Table S6).
LBC cohorts. Linear regression analyses were implemented in the R
statistical software package (http:www.r-project.org/), using models that
adjusted for age, sex and the first four MDS components for population
stratification. The cognitive phenotypes were assigned as the dependent
variable with polygenic score for autism or ADHD as the independent
variable. Results from the LBC1936 and LBC1921 analyses were combined
together and a fixed-effect meta-analysis performed to increase power.
Fixed-effect meta-analyses were carried out using the ‘meta’ package
implemented in R.
BATS. Linear regression analyses were carried out as in the LBC cohorts,
implemented in STATA (version 11, Statacorp, College Station, TX, USA).
RESULTS
Relationship of ASD polygenic score to cognition
Polygenic risk for ASD was positively associated with general
cognitive ability in GS:SFHS (beta = 0.07, P= 6× 10− 7). Polygenic
load for ASD in GS:SFHS was also associated with three of the
individual tests, delayed and immediate logical memory com-
bined (beta = 0.04, P= 1× 10− 4), performance on the Mill Hill
vocabulary test (beta = 0.05, P= 3× 10− 6) and verbal fluency
(beta = 0.04, P= 2× 10− 4) (Table 1). These P-values all remain
significant after Bonferonni correction. Greater polygenic risk for
ASD was associated with better cognitive function across all four
of these measures in this large adult population. The effect sizes
are small. ASD polygenic scores explain o0.5% of the variance in
cognitive test scores in all cases (Figure 1). A positive relationship
between ASD polygenic risk scores and cognitive ability was
also found in BATS with FIQ (beta = 0.07, P= 0.029) and VIQ
Figure 1. Proportion of variance explained in cognitive test performance explained by autism spectrum disorder polygenic risk score derived
using five different P-value thresholds in the Generation Scotland: Scottish Family Health Study (GS:SFHS). Only tests significantly associated
with polygenic risk score are presented. LM, logical memory; MHV, Mill Hill vocabulary; VF, verbal fluency.
Table 1. Polygenic risk for ASD/ADHD generated from SNPs with P-value cutoff threshold of 0.5 and tests of cognitive function in the Generation
Scotland (n= 9863) cohort, using mixed linear models implemented in ASReml-R, controlling for age and sex
Risk score Test Solution S.e Z-ratio Var P-value
ASD DSC 0.011 0.01 1.182 2 × 10− 5 0.237
Logical Memory 0.039 0.01 3.814 0.001 0.0001
MHV 0.047 0.01 4.64 0.002 0.000003
Verbal Fluency 0.040 0.01 3.757 0.001 0.0002
g 0.068 0.01 4.980 0.003 6×10−7
ADHD DSC − 0.015 0.01 − 1.702 0.0002 0.089
Logical Memory − 0.009 0.01 − 0.921 3 × 10− 7 0.357
MHV − 0.014 0.01 − 1.397 5 × 10− 5 0.162
Verbal Fluency 0.002 0.01 0.145 0 0.884
g − 0.010 0.01 − 0.760 0 0.45
Abbreviations: ADHD, attention-deficit hyperactivity disorder; ASD, autism spectrum disorder; DSC, digit symbol coding; g, general cognitive ability; MHV, Mill
Hill vocabulary; SNP, single-nucleotide polymorphism. P-value is derived from Wald Conditional F-test. Var, proportion of variance in test explained by
polygene score. Bold values signify Pr0.05.
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(beta = 0.07, P= 0.029) (Table 2). A fixed-effect meta-analysis of
general cognitive ability in GS:SFHS and LBC and FIQ in BATS
found a significant positive association of ASD risk with cognitive
ability (beta = 0.06, Z= 6.75, Po0.0001; Figure 2). In the LBC
cohorts, no significant associations with ASD polygenic risk were
found in the combined meta-analyses (Table 3). Additional
cognitive tests derived from the WMS-III and WAIS-III were also
tested for association with autism polygenic risk in LBC1936;
however, no significant associations were found (Supplementary
Table S2).
Relationship of ADHD polygenic score to cognition
No significant associations between polygenic risk for ADHD and
cognitive ability were found in GS:SFHS (Table 1). No significant
associations between polygenic risk for ADHD and cognitive
ability were found in BATS (Table 2). Polygenic risk for ADHD was
associated with age 11 IQ in the LBC1936 cohort; however, in
contrast to ASD, greater polygenic load was negatively correlated
with IQ (beta =− 0.09, P= 0.004). This result was not replicated in
LBC1921. A meta-analysis of the LBC1921 and LBC1936 revealed a
significant association with age 11 IQ (beta =− 0.08, Z=− 3.3,
P= 0.001), and this P-value remains significant after Bonferonni
correction for multiple testing. As previous studies have found
significant genetic covariance between ADHD and depression,5
statistical analyses were also carried out on the GS:SFHS control
individuals (n=7667) after removing those with a lifetime diagnosis
of depression. A negative association between ADHD polygenic
risk scores and DSC scores in GS:SFHS was significant when
depressed individuals were removed from the analysis (beta =
− 0.02, P= 0.03) (Supplementary Table S4).
DISCUSSION
This study found a positive association between common genetic
risk variants for ASD and general cognitive ability in individuals
drawn from the general population. ASD polygenic risk scores
were also positively correlated with measures of verbal fluency,
logical memory and vocabulary. In contrast, genetic risk for ADHD
was negatively correlated with age 11 IQ in members of the
combined Lothian Birth Cohorts, although this finding was not
confirmed in any of the other cohorts. The degree of genetic
overlap between ASD and ADHD attributable to common genetic
variation has previously been shown to be non-significant,5 and
therefore a differential effect of ASD and ADHD polygenic risk
scores is plausible. These results provide evidence that common
genetic variation associated with ASD confers better general
cognitive ability in a non-clinical population.
The rate of intellectual disability in autistic individuals is esti-
mated to be 70%16 although this is lower when broader ASDs are
included.52 A recent study examined the impact of copy number
variants associated with neuropsychiatric disease on cognition in
healthy controls.28 A rare chromosome 16p11.2 deletion, which is
a highly penetrant genetic risk factor in autism,53 was found to
significantly impair cognitive function in healthy control carriers.
In contrast, our results suggest that common genetic risk for
autism correlates positively with cognitive function. The relation-
ship between autism and intelligence may therefore be compli-
cated by the existence of distinct classes of genetic risk. Autism
has the highest twin heritability of all psychiatric disorders,54,55 yet
only 17% of this variance is attributable to common variants.5 This
discrepancy is most likely owing to rare and de novo mutations,
which are increasingly recognized as an important source of
genetic risk for autism56 and are negatively associated with
cognition in healthy individuals.28 Individuals with high function-
ing autism often display an atypical Wechsler intelligence profile,
with strengths on matrix reasoning and block design and weak-
nesses on DSC and symbol search subtests.57–60 We did not find
any evidence that genetic risk for autism in non-clinical individuals
was consistently associated with strengths or weaknesses in any of
these domains. It is notable, however, that in the GS:SFHS, DSC
Table 2. Polygenic risk for ASD/ADHD in BATS sample (n= 921)
generated from SNPs with P-value cutoff threshold of 0.5 and the
relationship with cognitive ability, controlling for age and sex
Risk score Test Beta S.e t-value r2 P-value
ASD FIQ 0.073 0.03 2.19 0.005 0.029
PIQ 0.058 0.03 1.73 0.0028 0.085
VIQ 0.073 0.03 2.19 0.005 0.029
NART 0.023 0.04 0.65 0.0009 0.518
DSC 0.059 0.03 1.87 0.001 0.062
ADHD FIQ 0.042 0.03 1.29 0.002 0.199
PIQ 0.057 0.03 1.71 0.0028 0.087
VIQ 0.013 0.03 0.38 0.0003 0.702
NART 0.018 0.04 0.52 0.0007 0.606
DSC 0.017 0.03 0.56 0 0.579
Abbreviations: ADHD, attention-deficit hyperactivity disorder; ASD, autism
spectrum disorder; BATS, Brisbane Adolescent Twin Sample; DSC, digit
symbol coding; FIQ, full-scale intelligent quotient; NART, National Adult
Reading Test; PIQ, performance IQ; SNP, single-nucleotide polymorphism;
VIQ, verbal IQ. Bold values signify Pr0.05.
Figure 2. Forest plot showing effect size of polygenic risk for autism on general cognitive ability in the Generation Scotland Scottish Family
Health Study (GS:SFHS), Lothian Birth Cohort (LBC; LBC1936 and LBC1921) and full-scale IQ in Brisbane Adolescent Twin Sample (BATS). CI,
confidence interval; seTE, standard errors; TE, treatment effect (standardized regression coefficients); W(fixed), weight of individual studies in
fixed-effect meta-analysis.
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was the only test of cognition where individuals with high
polygenic profiles scores for autism did not perform better.
Individuals with ADHD typically have poorer cognitive abilities
than their age-matched counterparts. Executive function deficits
are found to persist into adulthood8 despite remission of ADHD
symptoms13,14 although other studies find impairments only in
individuals whose ADHD remains.15 Symptoms of ADHD, such as
hyperactivity and inattention, associate with scholastic impairment in
children drawn from a population-based sample.61 Furthermore,
polygenic risk for ADHD associates positively with hyperactivity
and impulsivity in the general population.62 We provide sugges-
tive evidence that polygenic risk for ADHD associates with ADHD-
like traits in the general population by showing a negative
relationship between age 11 IQ and ADHD genetic risk in the LBC.
We also demonstrate a weak negative association with DSC in GS:
SFHS when individuals with a lifetime diagnosis of depression
were removed from the sample. Taken together, these data
suggest that ADHD may lie on a continuous distribution of traits
present in the general population; however, the association of
ADHD polygenic risk and cognitive impairment should be inter-
preted cautiously and warrants further replication, as consistent
evidence for this was not found across all cohorts in this study.
Sex-specific analyses revealed a significant interaction between
sex and ASD polygenic risk score in the context of DSC in GS:SFHS,
indicating that genetic risk for ASD in females is positively
correlated with performance on DSC, in contrast to males. There is
a notable sex bias in ADHD and ASD prevalence, with roughly 2.5
males affected for every female for ADHD63 and 4 males for every
female affected in ASD.64 Interestingly, these data show that the
effects of ASD genetic risk on DSC performance are more
pronounced in females from the general population.
There are a number of limitations to this study that should be
noted. Consistent replication was not achieved across studies.
Polygenic risk for autism, although robustly associated with
cognition in GS:SFHS, only replicated in BATS. The failure to
consistently replicate the finding in GS:SFHS may be due to the
smaller sample size of the LBC cohorts. Furthermore, the LBCs
comprise older participants and measuring general cognitive
ability in this age group may have affected the results. Similarly,
ADHD was found to associate with age 11 IQ in the LBC cohort,
but this did not replicate in BATS or GS:SFHS, although the
relationship between cognitive function and ADHD risk was
negative in 4/5 tests in GS:SFHS. Furthermore, many of the signif-
icant P-values reported in this study are modest and do not
survive correction for multiple testing. The lack of replication may
have arisen from the unavoidable but significant heterogeneity
among cognitive tests across the three cohorts. A lack of power to
detect association in the smaller cohorts may also have contrib-
uted to the lack of replication. This is not unexpected when
considering the amount of variance in cognitive function we were
able to explain in GS:SFHS: o0.5% in all cases. This is consistent
with other studies that have employed polygenic risk scoring to
assess genetic overlap between disorders or across cohorts.
According to recent estimates, 32% of the genetic liability for
schizophrenia (SCZ) can be explained by common genetic
variation; however, using polygenic risk scores to predict SCZ
status in an independent cohort, only ~ 7% of the variance in
liability could be explained.65 The genetic variance explained by
common SNPs increases as a function of sample size. As the PGC
GWAS of ASD and ADHD were considerably smaller than the SCZ
GWAS (N for autism ~ 6700, ADHD ~16 000, SCZ ~ 150 000), the
degree of polygenic overlap between autism, ADHD and cognition
will be an underestimate.
The current study suggests that genetic risk for autism is posi-
tively correlated with cognitive function in non-clinical cohorts
and is likely to be independent of ASD pathology. The genetic
basis of ADHD and autism are poorly understood; however,
understanding the significant and opposing directions of geneticT
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covariance between these traits and cognitive function will
provide opportunities to investigate their biological origins.
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